Celator(R) Pharmaceuticals announces public offering of common stock and warrants
Celator announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. Roth Capital Partners and National Securities Corporation are acting as joint book-running managers. October 17, 2014